The Effect of Orally Administered Low-Dose Dronabinol on Retinal Blood Flow and Oxygen Metabolism in Healthy Subjects.

Purpose: The present study was performed to investigate the effect of oral dronabinol, a synthetic tetrahydrocannabinol derivate, on retinal hemodynamics in healthy subjects in a randomized, double-masked, placebo-controlled, 2-way crossover design. Methods: Twenty-four subjects received 5 mg dronab...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Ocular Pharmacology & Therapeutics Vol. 37; no. 6; pp. 360 - 367
Autores principales: Hommer, Nikolaus, Schmidl, Doreen, Kallab, Martin, Bauer, Martin, Werkmeister, René M., Schmetterer, Leopold, Abensperg-Traun, Marihan, Garhöfer, Gerhard
Formato: research randomized controlled trial Journal Article
Publicado: Mary Ann Liebert, Inc. Jul/Aug2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=151642676&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 151642676
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10807683
        2U7
      jtl: Journal of Ocular Pharmacology & Therapeutics
      issn: 10807683
      maglogo: N
    pubinfo:
      dt: Jul/Aug2021
      vid: 37
      iid: 6
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        151642676
        151642676
        NLM33999707
        151642676
        10.1089/jop.2020.0131
        NLM33999707
        151642676
      ppf: 360
      ppct: 7
      formats:
      tig:
        atl: The Effect of Orally Administered Low-Dose Dronabinol on Retinal Blood Flow and Oxygen Metabolism in Healthy Subjects.
      aug:
        au:
          Hommer, Nikolaus
          Schmidl, Doreen
          Kallab, Martin
          Bauer, Martin
          Werkmeister, René M.
          Schmetterer, Leopold
          Abensperg-Traun, Marihan
          Garhöfer, Gerhard
        affil: Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
      sug:
        subj:
          Oxygen Metabolism
          Cannabis Administration and Dosage
          Retina Physiology
          Blood Circulation
          Male
          Administration, Oral
          Blood Flow Velocity
          Female
          Retina Drug Effects
          Neurotransmitter Agents Administration and Dosage
          Adult
          Research Subjects
          Double-Blind Studies
          Crossover Design
          Human
          Dose-Response Relationship, Drug
          Comparative Studies
          Multicenter Studies
          Randomized Controlled Trials
          Evaluation Research
          Validation Studies
          Adult: 19-44 years
          Male
          Female
      ab: Purpose: The present study was performed to investigate the effect of oral dronabinol, a synthetic tetrahydrocannabinol derivate, on retinal hemodynamics in healthy subjects in a randomized, double-masked, placebo-controlled, 2-way crossover design. Methods: Twenty-four subjects received 5 mg dronabinol on 1 study day and placebo on the other study day. Total retinal blood flow (TRBF) was measured using a custom-built Doppler Optical Coherence Tomography system. Oxygen saturation of major retinal vessels was measured with a commercially available Dynamic Vessel Analyzer. Based on these parameters, retinal oxygen extraction was calculated. Measurements were performed before and after drug administration on both study days. Results: Placebo had no effect on TRBF, retinal arterial or venous oxygen content, and retinal oxygen extraction (P > 0.1 each). In contrast, dronabinol induced a significant increase in TRBF from 38.9 ± 6.1 to 40.7 ± 6.7 μL/min (P < 0.001), which was accompanied by a significant increase in retinal venous oxygen content (from 0.129 ± 0.008 to 0.132 ± 0.009 mL O2/mL, P = 0.02). As no change in retinal arterial oxygen content occurred (P = 0.12), retinal oxygen extraction remained stable (2.2 ± 0.4 μL vs. 2.2 ± 0.4 μL O2/min, P = 0.29). Conclusions: These results indicate that orally administered dronabinol increases TRBF in healthy subjects without altering retinal oxygen extraction. The drug may therefore be a candidate for improving perfusion in patients with ocular vascular disease.
      pubtype: Academic Journal
      doctype:
        research
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N